A detailed history of Tower Research Capital LLC (Trc) transactions in Generation Bio Co. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 13,447 shares of GBIO stock, worth $32,676. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,447
Previous 4,584 193.35%
Holding current value
$32,676
Previous $18,000 105.56%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$2.64 - $4.35 $23,398 - $38,554
8,863 Added 193.35%
13,447 $37,000
Q1 2024

May 15, 2024

SELL
$1.73 - $4.07 $7,151 - $16,825
-4,134 Reduced 47.42%
4,584 $18,000
Q4 2023

Feb 13, 2024

BUY
$0.91 - $3.35 $78 - $288
86 Added 1.0%
8,718 $14,000
Q3 2023

Nov 14, 2023

BUY
$3.65 - $6.9 $16,654 - $31,484
4,563 Added 112.14%
8,632 $32,000
Q2 2023

Aug 14, 2023

BUY
$3.5 - $5.67 $556 - $901
159 Added 4.07%
4,069 $22,000
Q1 2023

May 09, 2023

BUY
$3.61 - $7.01 $2,209 - $4,290
612 Added 18.56%
3,910 $17,000
Q4 2022

Feb 10, 2023

SELL
$3.66 - $6.77 $10,540 - $19,497
-2,880 Reduced 46.62%
3,298 $13,000
Q3 2022

Nov 10, 2022

SELL
$4.68 - $8.34 $21,326 - $38,005
-4,557 Reduced 42.45%
6,178 $33,000
Q2 2022

Aug 15, 2022

BUY
$4.87 - $9.41 $46,795 - $90,420
9,609 Added 853.37%
10,735 $70,000
Q1 2022

May 12, 2022

SELL
$4.16 - $7.76 $17,605 - $32,840
-4,232 Reduced 78.98%
1,126 $8,000
Q4 2021

Feb 14, 2022

BUY
$5.99 - $24.97 $5,097 - $21,249
851 Added 18.88%
5,358 $38,000
Q3 2021

Nov 15, 2021

BUY
$20.0 - $27.43 $34,060 - $46,713
1,703 Added 60.73%
4,507 $113,000
Q2 2021

Aug 16, 2021

BUY
$24.34 - $38.34 $24,899 - $39,221
1,023 Added 57.44%
2,804 $75,000
Q1 2021

May 17, 2021

BUY
$24.74 - $40.2 $5,269 - $8,562
213 Added 13.58%
1,781 $51,000
Q4 2020

Feb 16, 2021

SELL
$21.68 - $51.61 $16,845 - $40,100
-777 Reduced 33.13%
1,568 $44,000
Q3 2020

Nov 16, 2020

BUY
$18.07 - $31.84 $42,374 - $74,664
2,345 New
2,345 $72,000

Others Institutions Holding GBIO

About Generation Bio Co.


  • Ticker GBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,011,200
  • Market Cap $143M
  • Description
  • Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...
More about GBIO
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.